US and Singapore scientists get COVID-19 vaccine trial approved

# 18:35
22 July 2020

Singapore’s Health Sciences Authority stated on Wednesday it has approved clinical trials for a COVID-19 vaccine candidate dubbed LUNAR-COV19, developed by American biopharmaceutical company Arcturus Therapeutics and the local Duke-NUS Medical school, APA reports citing Teletrader.

According to the joint statement, human testing on 108 volunteers will be conducted in a fast manner.

Professor Ooi Eng Eong, deputy director of the emerging infectious diseases program at Duke-NUS, stated that "a single dose of this vaccine may be sufficient to trigger robust and durable immune responses."